These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35125316)

  • 1. [Intravesical instillations for inflammatory and sensory chronic bladder diseases: Literature review and guide to clinical practice].
    Meyer F; Chen É; Berrogain N; Bosset PO; Campagne-Loiseau S; Cardot V; Charles T; Deffieux X; Donon L; Even L; Girard F; Hermieu JF; Hurel S; Klap J; Peyrat L; Thuillier C; Tibi B; Vidart A; Wagner L; Cornu JN
    Prog Urol; 2022 Apr; 32(5):388-399. PubMed ID: 35125316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical glycosaminoglycans in the management of chronic cystitis.
    Iacovelli V; Topazio L; Gaziev G; Bove P; Vespasiani G; Finazzi Agrò E
    Minerva Urol Nefrol; 2013 Dec; 65(4):249-62. PubMed ID: 24091478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial.
    Nordling J; van Ophoven A
    Arzneimittelforschung; 2008; 58(7):328-35. PubMed ID: 18751498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans--a review.
    Madersbacher H; van Ophoven A; van Kerrebroeck PE
    Neurourol Urodyn; 2013 Jan; 32(1):9-18. PubMed ID: 22782909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up.
    Imperatore V; Creta M; Di Meo S; Buonopane R; Longo N; Fusco F; Spirito L; Imbimbo C; Mirone V
    Arch Ital Urol Androl; 2018 Mar; 90(1):11-14. PubMed ID: 29633792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycan Replacement Therapy with Intravesical Instillations of Combined Hyaluronic Acid and Chondroitin Sulfate in Patients with Recurrent Cystitis, Post-radiation Cystitis and Bladder Pain Syndrome: A Narrative Review.
    Poletajew S; Brzózka MM; Krajewski W; Kamecki H; Nyk Ł; Kryst P
    Pain Ther; 2024 Feb; 13(1):1-22. PubMed ID: 37917298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations on the use of intravesical hyaluronic acid instillations in bladder pain syndrome.
    Madurga Patuel B; González-López R; Resel Folkersma L; Machado Fernández G; Adot Zurbano JM; Bonillo MÁ; Vozmediano Chicharro R; Zubiaur Líbano C
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):131-137. PubMed ID: 35256323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
    J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome.
    Pyo JS; Cho WJ
    Cell Physiol Biochem; 2016; 39(4):1618-25. PubMed ID: 27627755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Available evidence about efficacy of different restoring agents of glycosaminoglycans for intravesical use in interstitial cystitis].
    Arance I; Ramón de Fata F; Angulo JC; González-Enguita C; Errando C; Cozar JM; Esteban M
    Actas Urol Esp; 2013 Feb; 37(2):92-9. PubMed ID: 23260184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and safety of intravesical hyaluronic acid for symptom control in chronic bladder diseases.].
    Boronat Catalá J; García Tello A; González Montes L; Ruiz Graña S; Torres Pérez D; Llanes González L
    Arch Esp Urol; 2021 Sep; 74(7):639-644. PubMed ID: 34472431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome.
    Jensen MM; Jia W; Schults AJ; Isaacson KJ; Steinhauff D; Green B; Zachary B; Cappello J; Ghandehari H; Oottamasathien S
    Biomaterials; 2019 Oct; 217():119293. PubMed ID: 31276948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis.
    Wyndaele JJJ; Riedl C; Taneja R; Lovász S; Ueda T; Cervigni M
    Neurourol Urodyn; 2019 Feb; 38(2):535-544. PubMed ID: 30592544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.
    Cervigni M; Natale F; Nasta L; Padoa A; Voi RL; Porru D
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):943-7. PubMed ID: 18338095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.
    Toft BR; Nordling J
    Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
    Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
    Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Painful bladder syndrome and interstitial cystitis: treatment options.
    Fiander N
    Br J Nurs; 2013 May 9-22; 22(9):S26, S28-33. PubMed ID: 23752572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.